Disruption of RFX family transcription factors causes autism, attention-deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior
Holly K. Harris(Boston Children's Hospital), Christopher Gray(Children's Hospital of Philadelphia), Emanuele Agolini(Bambino Gesù Children's Hospital), Nikoleta Argyrou(Boston Children's Hospital), Christina Fagerberg(Odense University Hospital), George E. Tiller(Kaiser Permanente), Catharina M.L. Volker‐Touw(University Medical Center Utrecht), Emily Fassi(Washington University in St. Louis), Antonio Novelli(Bambino Gesù Children's Hospital), Kimberly A. Aldinger(Seattle Children's Hospital), Maria Kibæk(Odense University Hospital), Catherine A. Buchanan(Dell Children's Medical Center of Central Texas), Rolph Pfundt(Radboud University Nijmegen), Cara Skraban(Children's Hospital of Philadelphia), Peter D. Turnpenny(University of Exeter), Ada Hamosh(Johns Hopkins University), Reza Asadollahi(University of Zurich), Thatjana Gardeitchik(Radboud University Nijmegen), Anita Rauch(University of Zurich), Koen L.I. van Gassen(University Medical Center Utrecht), Tojo Nakayama(Boston Children's Hospital), Gaëtan Lesca(Hospices Civils de Lyon), Julian L. Ambrus(University at Buffalo, State University of New York), Ellen van Binsbergen(University Medical Center Utrecht), Paranchai Boonsawat(University of Zurich), Laurence E. Walsh(Indiana University Health), Tomi L. Toler(Washington University in St. Louis), Karen W. Gripp(Alfred I. duPont Hospital for Children), Bert B.A. de Vries(Radboud University Nijmegen), Marleen Simon(Erasmus University Rotterdam), Lance H. Rodan(Boston Children's Hospital), Madeleine Fannemel(Oslo University Hospital), Aubrie Soucy(Institut thématique Génétique, génomique et bioinformatique), Fleur Vansenne(University Medical Center Groningen), Alice Poisson(Université Claude Bernard Lyon 1), Carolyn Applegate(Johns Hopkins University), Victoria Suslovitch(Boston Children's Hospital), Boxun Zhao(Broad Institute), Jorune Balciuniene(Children's Hospital of Philadelphia), Jenny Lai(Brigham and Women's Hospital), Casie A. Genetti(Boston Children's Hospital), Katelyn Payne(Indiana University Health), Martin J. Larsen(University of Southern Denmark), Cynthia S. Gubbels(Boston Children's Hospital), Laura Baker(DuPont (United States)), Audrey Labalme(Hospices Civils de Lyon), Jennifer E. Posey(Baylor College of Medicine), Marcia Willing(Washington University in St. Louis), LaDonna Immken(Dell Children's Medical Center of Central Texas)
Cited by 91
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|808
Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation
|New England Journal of Medicine|2016|774
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
|Nature Genetics|2012|752